COMMUNIQUÉ DE PRESSE publié le 05/12/2023 à 14:30, il y a 11 mois 16 jours Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023 Applied DNA Sciences, Inc. (NASDAQ:APDN) will release its Q4 and full year 2023 financial results on December 7, 2023, after the market close. A conference call for investors will follow to discuss the results Financial Results Conference Call Investor Relations Applied DNA Sciences NASDAQ:APDN
COMMUNIQUÉ DE PRESSE publié le 28/11/2023 à 14:30, il y a 11 mois 23 jours Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
COMMUNIQUÉ DE PRESSE publié le 16/11/2023 à 14:30, il y a 1 année Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
COMMUNIQUÉ DE PRESSE publié le 09/11/2023 à 15:15, il y a 1 année Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
COMMUNIQUÉ DE PRESSE publié le 14/09/2023 à 15:00, il y a 1 année 2 mois Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
COMMUNIQUÉ DE PRESSE publié le 06/09/2023 à 15:00, il y a 1 année 2 mois Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
COMMUNIQUÉ DE PRESSE publié le 29/08/2023 à 15:00, il y a 1 année 2 mois Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit
COMMUNIQUÉ DE PRESSE publié le 23/08/2023 à 15:30, il y a 1 année 2 mois Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production
COMMUNIQUÉ DE PRESSE publié le 10/08/2023 à 22:05, il y a 1 année 3 mois Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
COMMUNIQUÉ DE PRESSE publié le 07/08/2023 à 17:00, il y a 1 année 3 mois Applied DNA to Report Third Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, August 10, 2023
Publié le 21/11/2024 à 06:58, il y a 9 heures 42 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 9 heures 42 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 9 heures 42 minutes Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 20 heures 32 minutes Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 21 heures 20 minutes Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Publié le 21/11/2024 à 16:01, il y a 39 minutes Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Publié le 21/11/2024 à 16:00, il y a 40 minutes Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Publié le 21/11/2024 à 16:00, il y a 40 minutes Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Publié le 21/11/2024 à 15:30, il y a 1 heure 10 minutes CLS Health Opens New Comprehensive Care Clinic in Sugar Creek
Publié le 21/11/2024 à 15:24, il y a 1 heure 15 minutes Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Publié le 21/11/2024 à 15:23, il y a 1 heure 17 minutes Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Publié le 21/11/2024 à 15:22, il y a 1 heure 18 minutes Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
